Medtronic (MDT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Medtronic (MDT) last issued guidance on June 3, 2026 for fiscal year 2027. The company guided earnings per share in the range of $5.9 - $6, compared to a consensus EPS estimate of $6.06.
Compared to prior guidance, Medtronic raised its EPS outlook from a previous range of $5.62 - $5.66.
Medtronic has issued 17 guidance updates between August 23, 2022 and June 3, 2026. During this period, the company raised its outlook 5 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.55 | $1.33 | $1.31 | $1.23 |
| Actual | $1.55 | $1.36 | $1.36 | $1.26 |
| Surprise | 0.00% | +2.26% | +3.82% | +2.44% |
| Revenue | ||||
| Estimate | $9.62B | $8.89B | $8.86B | $8.37B |
| Actual | $9.81B | $9.02B | $8.96B | $8.58B |
| Surprise | +1.91% | +1.39% | +1.12% | +2.48% |
| Metric | Q1 '27E | Q2 '27E | Q3 '27E | Q4 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.39 | $1.35 | $1.44 | $1.77 |
| Revenue | ||||
| Consensus | $9.53B | $9.49B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Jun 3, 2026 | $1.55 | $1.55 | 0.00 % |
| Q3 | Feb 17, 2026 | $1.36 | $1.33 | 2.26 % |
| Q2 | Nov 18, 2025 | $1.36 | $1.31 | 3.82 % |
| Q1 | Aug 19, 2025 | $1.26 | $1.23 | 2.44 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Jun 3, 2026 | $9.81B | $9.62B | 1.91 % |
| Q3 | Feb 17, 2026 | $9.02B | $8.89B | 1.39 % |
| Q2 | Nov 18, 2025 | $8.96B | $8.86B | 1.12 % |
| Q1 | Aug 19, 2025 | $8.58B | $8.37B | 2.48 % |